SINOPEP-ALLSINO BIOPHARMACEUTICAL CO., LTD

SINOPEP Jiangsu Inc. is dedicated to supporting worldwide pharmaceutical and biotech companies by developing and manufacturing protein, peptide, and non-peptidic biochemicals as Active Pharmaceutical Ingredients (APIs). We manufacture APIs and peptides under current Good Manufacturing Practice (cGMP). Our new cGMP commercial-scale manufacturing base covers an area of 1,200,000 square feet. We're committed to supporting for your IND, NDA, ANDA, and other regulatory applications.
 

In 2011, we created SINOPEP R&D Lab For Peptide New Drug Development intended to provide expertise and resources to maximize the potential of Sinopep’s discoveries. We promise that 8-10％ of our annual sales will contribute to this Lab. As a research-oriented company, our service covers:

- new drug development (protein and peptide drugs)
- CRO outsourcing services (custom peptide synthesis)
- APIs cGMP commercialization manufacturing.

With a vision towards helping people lead healthier, better lives, Sinopep has rapidly emerged as one of the premier pharmaceutical companies in providing quality, cGMP compliant peptides and APIs in China.